This study was an interventional study in a randomized, controlled clinical trial with the aim of effecting nettle (Neonatal Pill) on sleep quality in hemodialysis patients. The statistical population of this study included 90 male and female patients referring to the center of Sari for hemodialysis. The criteria for entering the study include consenting to participate in the research; dialysis treatment at least two times a week, at least 3 months, and 18 years of age and older. Exit criteria also include known psychiatric disorders, diabetes mellitus, urticaria, Myomia or fibroma; menorrhagia; history of gastrointestinal bleeding; mental disorders; heart failure; coronary artery stenosis or myocardial infarction; systolic blood pressure less than 90 mm Hg and substance abuse. Urtica dioica nettle pepper with Netanyon 400 mg brandy. Based on at least 3.1 milligrams of chlorogenic acid in each tablet made from the dried extract of the leaf of the nettle of the nettle plant by Barij Essen, it is used 3 times a day for 3 months in this study.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2017081419677N3
Registration date:2017-10-30, 1396/08/08
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2017-10-30, 1396/08/08
Registrant information
Name
Ravanbakhsh Esmaeili
Name of organization / entity
Mazandaran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 11 3336 7345
Email address
r.esmaeili@mazums.ac.ir
Recruitment status
Recruitment complete
Funding source
Mazandaran University of Medical Sciences
Expected recruitment start date
2017-10-23, 1396/08/01
Expected recruitment end date
2018-04-21, 1397/02/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of nettle(Netonal Barij) on sleep quality in hemodialysis patients
Public title
The effect of nettle(Netonal Barij) on sleep quality in hemodialysis patients
Purpose
Health service research
Inclusion/Exclusion criteria
The criteria for entering the study include consenting to participate in research, dialysis treatment at least two times a week, at least 3 months, and 18 years of age and older. Exit criteria also include known psychiatric disorders, diabetes mellitus, urticaria ; Myomia; menorrhagia; history of gastrointestinal bleeding; mental disorders; heart failure; coronary artery stenosis or myocardial infarction; systolic blood pressure less than 90 mm Hg and substance abuse
Age
From 18 years old to 85 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
90
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Single blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Mazandaran university of Medical sciences
Street address
Mazandaran university of medical science,vice chancellor for resea